BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2862244)

  • 1. Distribution of azapropazone and its principal 8-hydroxy-metabolite in plasma, urine and gastrointestinal mucosa determined by HPLC.
    Rainsford KD
    J Pharm Pharmacol; 1985 May; 37(5):341-5. PubMed ID: 2862244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The determination of azapropazone and its 6-hydroxy metabolite in plasma and urine by HPLC.
    Kline BJ; Wood JH; Beightol LA
    Arzneimittelforschung; 1983; 33(4):504-6. PubMed ID: 6683526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determination of azapropazone in blood plasma.
    Leach H
    Curr Med Res Opin; 1976; 4(1):35-43. PubMed ID: 1261300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of azapropazone and 8-hydroxyazapropazone in urine by direct quantitative thin-layer chromatography (author's transl)].
    Geissler HE; Faust-Tinnefeldt G; Mutschler E
    Arzneimittelforschung; 1978; 28(8):1430-1. PubMed ID: 582413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of azapropazone following single oral and intravenous doses.
    Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
    Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human pharmacokinetics of different i.v. doses of azapropazone (HPLC-determination) (author's transl)].
    Gikalov I; Kaufmann R; Schuster O
    Arzneimittelforschung; 1982; 32(4):423-6. PubMed ID: 7201814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic evaluation of the effect of azapropazone on the gastric mucosa.
    Hradsky M; Bruce L
    Scand J Rheumatol; 1978; 7(1):31-2. PubMed ID: 675173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of azapropazone in synovial tissues and fluid.
    Spahn H; Thabe K; Mutschler E; Tillmann K; Gikalov I
    Eur J Clin Pharmacol; 1987; 32(3):303-7. PubMed ID: 3595703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of azapropazone in the elderly.
    Ritch AE; Perera WN; Jones CJ
    Br J Clin Pharmacol; 1982 Jul; 14(1):116-9. PubMed ID: 7104163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa: relationship to drug uptake.
    Rainsford KD; Fox SA; Osborne DJ
    Scand J Gastroenterol Suppl; 1984; 101():55-68. PubMed ID: 6443622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HPLC determination of azapropazone in human plasma].
    Spahn H; Mutschler E
    Arch Pharm (Weinheim); 1983 Jan; 316(1):42-7. PubMed ID: 6830416
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the determination of azapropazone from plasma by direct quantitative thin-layer chromatography (author's transl)].
    Geissler HE; Mutschler E; Faust-Tinnefeldt G
    Arzneimittelforschung; 1977; 27(9):1713-5. PubMed ID: 579143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Azapropazone plasma levels under simultaneous treatment with an antacid or laxative].
    Faust-Tinnefeldt G; Geissler HE; Mutschler E
    Arzneimittelforschung; 1977; 27(12):2411-4. PubMed ID: 580058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition of xanthine oxidase by azapropazone and 8-hydroxy-azapropazone.
    Jahn U; Thiele K
    Arzneimittelforschung; 1988 Apr; 38(4):507-8. PubMed ID: 3401265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology and pharmacokinetics of azapropazone - a review.
    Jones CJ
    Curr Med Res Opin; 1976; 4(1):3-16. PubMed ID: 770078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between azapropazone and warfarin.
    McElnay JC; D'Arcy PF
    Br Med J; 1977 Sep; 2(6089):773-4. PubMed ID: 912313
    [No Abstract]   [Full Text] [Related]  

  • 17. Disposition of azapropazone in chronic renal and hepatic failure.
    Breuing KH; Gilfrich HJ; Meinertz T; Wiegand UW; Jähnchen E
    Eur J Clin Pharmacol; 1981; 20(2):147-55. PubMed ID: 7262176
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma protein binding of azapropazone in patients with kidney and liver disease.
    Jähnchen E; Blanck KJ; Breuing KH; Gilfrich HJ; Meinertz T; Trenk D
    Br J Clin Pharmacol; 1981 Apr; 11(4):361-7. PubMed ID: 7259929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amphiprotic character of azapropazone and its relevance to the gastric mucosa.
    McCormack K; Brune K
    Arch Toxicol; 1990; 64(1):1-6. PubMed ID: 2407231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatographic analysis of azapropazone and related benzotriazines.
    Ross MS
    J Chromatogr; 1977 Jan; 131():448-52. PubMed ID: 853106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.